Post by
JDavenport on Jun 20, 2022 5:34pm
The Plan
I've heard enough stuff for now. It's obvious that this is a play to move Bioasis into a larger arena. It looks like you're all going to make money. The Cresence people took the stock. Is that their play or is there a bigger win for them? The BIG Vancouver Broker who claims control of 90% of Bioasis stock seems happy with the plans that he seems to know and nobody else knows. Talk to him, not me.
xB3-001 appeared by mistake at the D&P Show, further proof of carelessness in investor relations. So, who was actually meant to see that xB3-001 information and why?
A full Cresence/EGF1 update of the website and corporate presentation should have been completed before the PR and then their posting to the Bioasis website triggered by the PR. Wasn't done! Are there secrets that can't be revealed yet?
Rollback of 30 to 1 is what I heard, or at least what a couple of people claim to have understood in conversations. A hundred million shares down to 3 million? Wow! What then? An IPO that dilutes current shareholders to nothing? Another IR fiasco!
Meanwhile, the readers of this forum are on their own. There is now way that anybody can offer a legitimate opinion, pro or con, about the current state and future plans for Bioasis.
Usually we would say, follow the money. In this case, the money to follow is expressed in shares, and rollback of shares and new owners, likely new Cresence board members, and liquidity events, and Nasdaq and another partner or two and Ladenburg Thalmann and who knows what.
The message out of Bioasis is a mess. Look for more information when the Q1 report comes out at the end of July, or after a half dozen press releases come out over the summer, or after the AGM so that you'll be voting without the information that others have and aren't sharing.
I have nothing to say about it all for now.
jd